caa a22 4500 477129331 CHVBK 20180405111700.0 cr unu---uuuuu 170330e19970901xx s 000 0 eng 10.1023/A:1018483405637 doi (NATIONALLICENCE)springer-10.1023/A:1018483405637 Incidence and mortality of neuroblastoma in Canada compared with other childhood cancers [Elektronische Daten] [R.-N. Gao, I. Levy, W. Woods, B. Coombs, L. Gaudette, G. Hill] The incidence and mortality of neuroblastoma was reviewed in thegeneral context of childhood cancer in Canada for the periods 1982-86 and1987-91. This was done to complement the preliminary work of the QuebecNeuroblastoma Screening Project that is studying the impact of screeningNorth American infants for the preclinical detection of neuroblastoma onpopulation-based mortality. Annual age-standardized incidence rates for allchild-hood cancer in Canada appear to have declined slightly(nonsignificantly) from155.1 to 150.8 per million, between 1982-86 and1987-91; the rates for neuroblastoma were stable between the two five-yearperiods (11.8 per million in 1982-86 and 11.4 per million in 1987-91). Withrespect to mortality, the age-standardized rates for childhood cancer inCanada have shown a declining trend between the first and second halves ofthe decade, from 43.4 to 34.7 per million, while the rates for neuroblastomahave not changed (4.4 and 4.2 per million). The age -specific distributionsof incident cancers indicate that neuroblastoma accounts for the greatestproportion of all cancers in children less than one year of age. Similarly,neuroblastoma is the leading cause of cancer deaths in children aged one tofour years. Theoretically, infants less than one year of age could benefitmost from effective preventive interventions, treatment, andresearch. Chapman and Hall, 1997 Canada nationallicence child nationallicence incidence nationallicence mortality nationallicence neuroblastoma nationallicence screening nationallicence Gao R.-N Health Statistics Division, Statistics Canada, Ottawa, Canada aut Levy I. Cancer Bureau, Laboratory Centre for Disease Control, Health Canada, Ottawa, Canada aut Woods W. South Carolina Cancer Center, Richland Memorial Hospital, Columbia, USA aut Coombs B. Cancer Bureau, Laboratory Centre for Disease Control, Health Canada, Ottawa, Canada aut Gaudette L. Health Statistics Division, Statistics Canada, Ottawa, Canada aut Hill G. Cancer Bureau, Laboratory Centre for Disease Control, Health Canada, Ottawa, Canada aut Cancer Causes & Control Kluwer Academic Publishers 8/5(1997-09-01), 745-754 0957-5243 8:5<745 1997 8 10552 https://doi.org/10.1023/A:1018483405637 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1023/A:1018483405637 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Gao R.-N Health Statistics Division, Statistics Canada, Ottawa, Canada aut NATIONALLICENCE 700 1- Levy I. Cancer Bureau, Laboratory Centre for Disease Control, Health Canada, Ottawa, Canada aut NATIONALLICENCE 700 1- Woods W. South Carolina Cancer Center, Richland Memorial Hospital, Columbia, USA aut NATIONALLICENCE 700 1- Coombs B. Cancer Bureau, Laboratory Centre for Disease Control, Health Canada, Ottawa, Canada aut NATIONALLICENCE 700 1- Gaudette L. Health Statistics Division, Statistics Canada, Ottawa, Canada aut NATIONALLICENCE 700 1- Hill G. Cancer Bureau, Laboratory Centre for Disease Control, Health Canada, Ottawa, Canada aut NATIONALLICENCE 773 0- Cancer Causes & Control Kluwer Academic Publishers 8/5(1997-09-01), 745-754 0957-5243 8:5<745 1997 8 10552 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer